Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Akturk HK, Nally LM, Lal RA, Warren ML, Demeterco-Berggren C, Forlenza GP, Reed JC, Shulman DI, Kipnes MS, Bode BW, Dewan AK, Liljenquist DR, Kudva YC, Niu F, Yovanovich C, Shin JJ, Cordero TL, McVean JJF, Vigersky RA, Bergenstal RM

Open source

DOI: 10.1177/15209156261444994
Published: 2026 Apr 28
Container: Diabetes technology & therapeutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/15209156261444994,
  title = {Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.},
  author = {Akturk HK and Nally LM and Lal RA and Warren ML and Demeterco-Berggren C and Forlenza GP and Reed JC and Shulman DI and Kipnes MS and Bode BW and Dewan AK and Liljenquist DR and Kudva YC and Niu F and Yovanovich C and Shin JJ and Cordero TL and McVean JJF and Vigersky RA and Bergenstal RM},
  year = {2026},
  journal = {Diabetes technology \& therapeutics},
  doi = {10.1177/15209156261444994},
  url = {https://doi.org/10.1177/15209156261444994}
}

RIS

TY  - JOUR
TI  - Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
AU  - Akturk HK
AU  - Nally LM
AU  - Lal RA
AU  - Warren ML
AU  - Demeterco-Berggren C
AU  - Forlenza GP
AU  - Reed JC
AU  - Shulman DI
AU  - Kipnes MS
AU  - Bode BW
AU  - Dewan AK
AU  - Liljenquist DR
AU  - Kudva YC
AU  - Niu F
AU  - Yovanovich C
AU  - Shin JJ
AU  - Cordero TL
AU  - McVean JJF
AU  - Vigersky RA
AU  - Bergenstal RM
PY  - 2026
JO  - Diabetes technology & therapeutics
DO  - 10.1177/15209156261444994
UR  - https://doi.org/10.1177/15209156261444994
ER  -

APA

HK, A., LM, N., RA, L., ML, W., C, D., GP, F., JC, R., DI, S., MS, K., BW, B., AK, D., DR, L., YC, K., F, N., C, Y., JJ, S., TL, C., JJF, M., RA, V., & RM, B. (2026). Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.. Diabetes technology & therapeutics. https://doi.org/10.1177/15209156261444994

Source records

pubmed · retrieved 2026-09-25T13:30:12.923Z